Pacific Biosciences Of California (PACB) Current Leases (2019 - 2026)

Pacific Biosciences Of California has reported Current Leases for 8 years, with the latest figure at $1.4 million in Q2 2026.

• On a quarterly basis, Current Leases rose 95.02% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $1.4 million, a 95.02% increase from a year earlier, with the FY2025 full-year figure at $448000.0, down 95.53% from the prior year.
• Current Leases was $1.4 million for Q2 2026 at Pacific Biosciences Of California, up from $277000.0 in the prior quarter.
• The five-year high for Current Leases was $12.5 million in Q2 2024, with the low at $277000.0 in Q1 2026.
• Average Current Leases over 5 years is $6.7 million, with a median of $8.7 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Current Leases plunged 95.53% in 2025, then surged 95.02% in 2026.
• Over 5 years, Current Leases stood at $8.9 million in 2022, then climbed by 7.93% to $9.6 million in 2023, then rose by 4.54% to $10.0 million in 2024, then slumped by 95.53% to $448000.0 in 2025, then surged by 206.03% to $1.4 million in 2026.
• The last three Current Leases figures came in at $1.4 million (Q2 2026), $277000.0 (Q1 2026), and $448000.0 (Q4 2025), per Business Quant data.